X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38871) 38871
Magazine Article (492) 492
Book / eBook (103) 103
Book Review (29) 29
Newsletter (29) 29
Web Resource (22) 22
Conference Proceeding (15) 15
Dissertation (9) 9
Publication (7) 7
Book Chapter (6) 6
Government Document (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35927) 35927
antidepressive agents - therapeutic use (25861) 25861
male (18393) 18393
female (18281) 18281
psychiatry (14262) 14262
adult (13353) 13353
middle aged (11607) 11607
antidepressants (8801) 8801
depression (8525) 8525
depressive disorder - drug therapy (8241) 8241
aged (7725) 7725
pharmacology & pharmacy (7319) 7319
treatment outcome (7281) 7281
depression - drug therapy (6861) 6861
neurosciences (5414) 5414
animals (5383) 5383
depressive disorder, major - drug therapy (5081) 5081
antidepressive agents - adverse effects (5071) 5071
antidepressive agents, tricyclic - therapeutic use (5040) 5040
adolescent (4664) 4664
clinical neurology (4542) 4542
major depression (4347) 4347
depression, mental (4043) 4043
antidepressive agents - pharmacology (4024) 4024
antidepressive agents, second-generation - therapeutic use (3892) 3892
serotonin uptake inhibitors - therapeutic use (3697) 3697
double-blind (3682) 3682
psychiatric status rating scales (3552) 3552
depressive disorder - psychology (3231) 3231
antipsychotic agents - therapeutic use (2839) 2839
psychotherapy (2795) 2795
drug therapy, combination (2723) 2723
major depressive disorder (2698) 2698
double-blind method (2677) 2677
risk factors (2648) 2648
fluoxetine (2515) 2515
drug therapy (2508) 2508
medicine, general & internal (2491) 2491
mental depression (2395) 2395
antidepressant (2322) 2322
comorbidity (2298) 2298
care and treatment (2270) 2270
antidepressive agents - administration & dosage (2230) 2230
time factors (2202) 2202
efficacy (2153) 2153
analysis (2123) 2123
depressive disorder - diagnosis (2120) 2120
rats (2114) 2114
young adult (2102) 2102
prevalence (2091) 2091
child (2083) 2083
dose-response relationship, drug (2031) 2031
combined modality therapy (2020) 2020
bipolar disorder - drug therapy (2012) 2012
depressive disorder - therapy (1977) 1977
psychology, clinical (1910) 1910
anxiety (1899) 1899
mice (1880) 1880
research (1857) 1857
clinical trials as topic (1779) 1779
aged, 80 and over (1778) 1778
follow-up studies (1732) 1732
depressive disorder, major - psychology (1731) 1731
randomized controlled trials as topic (1689) 1689
serotonin reuptake inhibitors (1687) 1687
severity of illness index (1680) 1680
serotonin (1661) 1661
fluoxetine - therapeutic use (1614) 1614
anti-anxiety agents - therapeutic use (1479) 1479
drugs (1455) 1455
risk (1442) 1442
placebo (1441) 1441
bipolar disorder (1429) 1429
depressive disorder, major - diagnosis (1427) 1427
antidepressive agents, second-generation - adverse effects (1421) 1421
disease models, animal (1402) 1402
symptoms (1401) 1401
serotonin uptake inhibitors - adverse effects (1372) 1372
disorder (1346) 1346
anticonvulsants - therapeutic use (1344) 1344
psychology (1341) 1341
retrospective studies (1336) 1336
depression - therapy (1329) 1329
metaanalysis (1329) 1329
antidepressive agents, tricyclic - adverse effects (1326) 1326
health aspects (1311) 1311
disorders (1305) 1305
depression - psychology (1247) 1247
drug interactions (1235) 1235
age factors (1226) 1226
depression - diagnosis (1226) 1226
cognitive therapy (1219) 1219
medicine & public health (1208) 1208
brain (1198) 1198
antidepressive agents (1197) 1197
pharmacotherapy (1189) 1189
prospective studies (1184) 1184
chronic disease (1175) 1175
depressive disorder, major - therapy (1165) 1165
placebo-controlled trial (1164) 1164
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (70) 70
Online Resources - Online (23) 23
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
UofT at Mississauga - Stacks (7) 7
St. Michael's College (John M. Kelly) - 2nd Floor (6) 6
UofT at Scarborough - Stacks (5) 5
UTL at Downsview - May be requested (4) 4
Gerstein Science - Periodical Stacks (2) 2
Robarts - Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Pharmacy (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Toronto East General Hospital - Chaplain Dept. (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35017) 35017
German (1285) 1285
French (1137) 1137
Russian (456) 456
Spanish (331) 331
Japanese (324) 324
Polish (200) 200
Italian (173) 173
Dutch (147) 147
Danish (122) 122
Swedish (108) 108
Portuguese (84) 84
Chinese (83) 83
Norwegian (83) 83
Hungarian (81) 81
Finnish (66) 66
Czech (53) 53
Romanian (21) 21
Hebrew (18) 18
Turkish (14) 14
Serbian (9) 9
Croatian (7) 7
Korean (7) 7
Icelandic (5) 5
Lithuanian (5) 5
Greek (3) 3
Ukrainian (3) 3
Slovak (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2012, Volume 2012, Issue 11, p. CD004851
.... Furthermore, there have been warnings against their use in this population due to concerns about increased risk of suicidal ideation and behaviour... 
Intervention | Condition | Paroxetine | SSRIs | Fluoxetine | Mental health | Induction Chemotherapy | Depressive disorder, major | Depression | Depressive Disorder | Antidepressive Agents | Suicide | Depressive disorders & major depression | Sertraline | Citalopram | Randomized Controlled Trials as Topic | Antidepressants | Child health | Mood disorders | Population | Child & Adolescent | Exclusively child and/or adolescent poopulation | Medicine General & Introductory Medical Sciences | Serotonin Uptake Inhibitors | Fluoxetine [adverse effects; therapeutic use] | RISK-FACTORS | Humans | SUICIDAL IDEATION | Citalopram [administration & dosage; therapeutic use] | Depressive Disorder [drug therapy; psychology] | MAJOR DEPRESSION | Sertraline [administration & dosage; therapeutic use] | PHARMACOLOGICAL-TREATMENT | PULSE CLOMIPRAMINE | SEROTONIN REUPTAKE INHIBITORS | MEDICINE, GENERAL & INTERNAL | Suicide [psychology] | COGNITIVE-BEHAVIORAL THERAPY | Paroxetine [adverse effects; therapeutic use] | Adolescent | TERM FOLLOW-UP | DOUBLE-BLIND | Antidepressive Agents [adverse effects; therapeutic use] | Serotonin Uptake Inhibitors [adverse effects; therapeutic use] | PLACEBO-CONTROLLED TRIAL | Child | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Depressive Disorder - drug therapy | Paroxetine - therapeutic use | Paroxetine - adverse effects | Antidepressive Agents - therapeutic use | Citalopram - administration & dosage | Sertraline - administration & dosage | Sertraline - therapeutic use | Suicide - psychology | Citalopram - therapeutic use | Antidepressive Agents - adverse effects | Depressive Disorder - psychology | Fluoxetine - therapeutic use | Fluoxetine - adverse effects
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 1/2013, Volume 170, Issue 1, pp. 23 - 30
Mood and substance use disorders commonly co-occur, yet there is little evidence-based research to guide the pharmacologic management of these comorbid disorders... 
CONTROLLED CLINICAL-TRIAL | NATIONAL EPIDEMIOLOGIC SURVEY | PSYCHIATRY | COMORBIDITY SURVEY REPLICATION | COCAINE DEPENDENCE | DOUBLE-BLIND | RANDOMIZED-TRIAL | PLACEBO-CONTROLLED TRIAL | MAJOR DEPRESSION | BIPOLAR DISORDER | ALCOHOL DEPENDENCE | Naltrexone - therapeutic use | Substance-Related Disorders - rehabilitation | Mood Disorders - psychology | Antipsychotic Agents - adverse effects | Humans | Sertraline - adverse effects | Alcoholism - diagnosis | Bipolar Disorder - diagnosis | Depressive Disorder, Major - epidemiology | Psychotropic Drugs - therapeutic use | Mood Disorders - epidemiology | Psychotropic Drugs - adverse effects | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Mood Disorders - rehabilitation | Sertraline - therapeutic use | Drug Therapy, Combination | Alcoholism - psychology | Antimanic Agents - adverse effects | Substance-Related Disorders - diagnosis | Bipolar Disorder - rehabilitation | Antimanic Agents - therapeutic use | Double-Blind Method | Comorbidity | Narcotic Antagonists - adverse effects | Depressive Disorder, Major - rehabilitation | Combined Modality Therapy | Controlled Clinical Trials as Topic | Alcoholism - epidemiology | Alcoholism - rehabilitation | Bipolar Disorder - psychology | Antidepressive Agents - therapeutic use | Depressive Disorder, Major - psychology | Narcotic Antagonists - therapeutic use | Mood Disorders - diagnosis | Substance-Related Disorders - psychology | Cognitive Therapy | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Naltrexone - adverse effects | Bipolar Disorder - epidemiology | Diagnosis, Dual (Psychiatry) | Psychological aspects | Drug abuse | Care and treatment | Physiological aspects | Mood (Psychology) | Psychotherapy | Health aspects | Methods
Journal Article